Fig. 2From: Safety and efficacy of autologous, adipose-derived mesenchymal stem cells in patients with rheumatoid arthritis: a phase I/IIa, open-label, non-randomized pilot trialJoint Counts. Swollen joint count showed a significant decrease at each of the follow-up visits compared to baseline. Tender joint scores showed highly significant decline at all follow-up weeks, compared to baseline. Significance defined at p value ≤ 0.01 (Holm–ŠÃdák correction for multiple comparisons), *p value < 0.01; **p value < 0.001; Wilcoxon-signed rank testBack to article page